A biochip is a device which assimilates one or more laboratory tasks on a sole chip to achieve high-throughput screening and automation. Advances in the field of nanotechnology have led to the development of lab-on-a-chip devices. Lab-on-a-chip can integrate several laboratory function in a few millimeters to a few square centimeters sized chip.

The report titled “Global Lab-on-a-Chip Market- Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall lab-on-a-chip market along with the market size and estimates for the duration 2017 to 2025. The research study covers in-depth analysis of market segments based on product type, application and different geographical region.

In order to help strategic decision makers, the report also includes competitive profiling of the leading players in global lab-on-a-chip market, attractive investment proposition and market positioning of key manufacturers sections. Other in-depth analysis provided in the report includes:

Geographically, the global lab-on-a-chip market is studied for the following regional markets:

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East and Africa

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2015-2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global lab-on-a-chip market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global lab-on-a-chip market. This report concludes with company profiles section that highlights major information about the key players engaged in global lab-on-a-chip market. In-depth competitive environment analysis and historical years (2015) market size data are also provided in the report. 

Thus, the research study provides a holistic view of the global lab-on-a-chip market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.

Based on the type of product, the lab-on-chip market is segmented into:

• DNA Microarrays
• Lab on a chip/Microfluidics
• Protein Microarrays
• Tissue Biochips
• Carbohydrate Biochips

A biochip device is a device which assimilates one or more laboratory tasks on a sole chip to achieve high-throughput screening and automation. Advances in the field of nanotechnology have led to the development of lab-on-a-chip devices. Lab-on-a-chip can integrate several laboratory function in a few millimeters to a few square centimeters sized chip. A biochip device is concerned with experiments carried out on a small scale, thus it helps achieve high-throughput automation and screening. The lab-on-a-chip market is segmented into DNA microarrays, lab on a chip/microfluidics, protein microarrays, tissue biochips and carbohydrate biochips. Protein arrays led the overall product market due to wide usage of in the proteomics to understand the better understanding of the human proteome, drug discovery, diagnostics and personalized medicines. DNA microarrays is anticipated to grow at the fastest rate to growing demand of personalized medicines, target therapies and research and development of cancer therapies.

Based on the type of application, the lab-on-a-chip market is segmented into:

• Genomics & Proteomics
• Diagnostics
• Drug Discovery
• Others

A lab-on-a-chip is a device that integrates one or more laboratory functions on a single integrated circuit or a chip to achieve automation and high-throughput screening. The application of lab-on-a-chip is increasing in different field of life sciences. From detecting breast cancer to screening for HIV, surviving serious disease, all of it is done with the help of a chip or a microarray.  LOC technology enables the use of small fluid volumes which helps cut costs and the analysis of reagents and response time. Several applications in life science and medicine have also been explored so far including potential use in protein crystallization studies and DNA or RNA sequencing. The applications student in the global lab-on-a-chip market include genomics & proteomics, diagnostics, drug discovery and others. The diagnostics segment held the largest share in the global lab-on-a-chip market by application. Early screening of breast cancer, HIV and other infectious diseases is driving the market for diagnostics segment. Genomics and proteomics are expected to grow at the highest rate due to rising research and development studies in genetic and sequencing to drive the market in the future.

For the purpose of this study, the global lab-on-a-chip market is categorized into:

• North America
• Europe
• Asia Pacific
• Latin America (LATAM)
• Middle East and Africa (MEA)

In the year 2016, North America emerged as the largest regional market for lab-on-a-chip market. The highest market share of the region is attributed to existence of evolved healthcare and biotechnology research infrastructure, availability of microarray chips in an affordable cost in the region encouraging the diagnostic applications. Favorable private and public funding in research and development in the U.S. makes it highest grossing country in North America. Asia Pacific is anticipated to be the fastest growing lab-on-a-chip market during the forecast period. Rapid entry of market leaders in the region, unmet medical needs, rising incidences of various infectious disease would further craft as a growth factor for the growth of Asia-Pacific lab-on-a-chip market. The competitors in the Asia Pacific market are budding and are continually working on introducing new clinical uses to augment value of lab-on-a-chip technology.